Larry B Goldstein1, Peter M Rothwell. Show Affiliations » 1. Department of Medicine (Neurology), Duke Stroke Center, Center for Clinical Health Policy Research, Duke University, Veterans Administration Medical Center, Durham, NC, USA. golds004@mc.duke.edu
Abstract
Mesh： See more » Anticoagulants/pharmacologyAnticoagulants/therapeutic useCarotid Stenosis/physiopathologyCarotid Stenosis/surgeryDelivery of Health Care/methodsDelivery of Health Care/trendsHealth Services Accessibility/statistics & numerical dataHealth Services Accessibility/trendsHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacologyHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useIntracranial Thrombosis/drug therapyIntracranial Thrombosis/physiopathologyIntracranial Thrombosis/prevention & controlPlatelet Aggregation Inhibitors/pharmacologyPlatelet Aggregation Inhibitors/therapeutic useRisk AssessmentStroke/drug therapyStroke/physiopathologyStroke/prevention & controlVascular Surgical Procedures/adverse effectsVascular Surgical Procedures/methodsVascular Surgical Procedures/trends
Substances： See more » AnticoagulantsHydroxymethylglutaryl-CoA Reductase InhibitorsPlatelet Aggregation Inhibitors
Year: 2010 PMID： 20075352 DOI： 10.1161/STROKEAHA.109.570531
Source DB: PubMed Journal: Stroke ISSN： 0039-2499 Impact factor: 7.914